Jpmorgan Chase & Co »

Ligand Pharmaceuticals In shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2012-06-30 $191k 12k 15.38
2010-12-31 $167k 19k 8.94

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Ligand Pharmaceuticals In

BlackRock
BlackRock
Vanguard Group
Henderson Group
Macquarie Group
Dimensional Fund Advisors
State Street Corporation
Stephens Investment Management Group
Congress Asset Management
Chicago Capital
St. Denis J. Villere & Co
Geode Capital Management
Rice Hall James & Associates
Ashford Capital Management
Impax Asset Management Group

View all funds holding Ligand Pharmaceuticals In